ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Gross Profit Over TimeContracting
Percentile Rank67
3Y CAGR+61.7%
5Y CAGR+7.4%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+61.7%/yr
vs +30.0%/yr prior
5Y CAGR
+7.4%/yr
Recent acceleration
Acceleration
+31.7pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.99B-15.8%
2025$3.55B+160.6%
2024$1.36B+92.6%
2023$706.89M-69.6%
2022$2.32B+11.4%
2021$2.09B-19.6%
2020$2.60B+948.3%
2019$247.80M-92.0%
2018$3.10B+293.9%
2017$786.60M-